Warning
Mae'r hysbyseb swydd hon wedi dod i ben ac mae'r ceisiadau wedi cau.
Senior Trust Doctor - Teenage & Young Adult Haematology/Oncology
| Dyddiad hysbysebu: | 20 Mehefin 2024 |
|---|---|
| Cyflog: | Heb ei nodi |
| Gwybodaeth ychwanegol am y cyflog: | £55,329 per annum + London Weighting |
| Oriau: | Llawn Amser |
| Dyddiad cau: | 20 Gorffennaf 2024 |
| Lleoliad: | London, NW1 2BU |
| Cwmni: | University College London Hospital |
| Math o swydd: | Cytundeb |
| Cyfeirnod swydd: | 6403959/309-UCLH-4555 |
Crynodeb
A Vacancy at University College London Hospitals NHS Foundation Trust.
We have an exciting opportunity for a Senior Clinical Fellow in TYA Haematology/Oncology (registrar/ST4+ equivalent), to join our busy and innovative Children’s and Young People’s Cancer Services [CYPCS] at UCLH from September 2024.
The post is for 12 months from September 2024. It is a 40-hour post: 8.30am to 5pm Monday to Friday, for on-call commitment for this post refer attached Job Description, which includes covering general paediatrics/paediatric emergency department.
This post will be comprised of 80% clinical activity and 20% for special interest activities, including disease focused research, service development projects, leadership and management skills training, diagnostics lab attachments.
Eligible for full registration with the GMC at time of appointment and hold a current licence to practise.
Full GMC Registration. NB: Non-UK trained doctors must be on the GMC register by date of interview.
This vacancy may close before the current listed closing date. Therefore, if you intend to apply for this post, you are advised not to delay submitting your completed application.
As part of the job, you will have the chance to develop expertise in a variety of subspecialities:
- Acute and chronic leukaemia’s
- Hodgkin and non-Hodgkin lymphomas
- Non-malignant haematology
- Neuro-oncology
- Sarcomas
- Rare tumours
- Bone Marrow Transplant (autologous and allogeneic)
- CAR T cells therapy
- Proton Beam Therapy
- Lab diagnostics (flow cytometry/cytogenetics/molecular/histopathology)
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological,gastrointestinaland oral disease. It has world class support services including critical care, imaging, nuclearmedicineand pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For the full Person Specification and more informationregardingthe main responsibilities of this role, please refer to the attached Job Description.
The TYA Service at UCLH is the largest in the world, attracting an international reputation, with regular visits from experts from around the globe. We provide comprehensive tertiary care for patients from diagnosis, through to survivorship or palliative care. We provide all aspects of state-of-the-art cancer care and are a quaternary centre for specific treatments, including radio-isotope therapy and proton beam therapy. The clinical service is enhanced by exceptional clinical and translational research based within University College London and the Institute of Child Health.
All patients aged 0-18 years with a diagnosis of cancer, within the North Thames TYA Cancer Network are referred into the UCLH/GOSH Principal Treatment Centre. Patients aged 19-24 years are offered the choice to be referred to UCLH or to be treated at local Designated Hospitals within the Operational Delivery Network (ODN).
The newly opened Grafton Way Hospital houses the Proton Beam Therapy (PBT) Centre, one of only two sites in the UK. PBT offers innovative radiotherapy for certain cancer patients, with children making a significant proportion providing new models of care, synergistic clinical provision and research opportunities. These children require extensive supportive and POSCU-like care, offering opportunities for the development of new services linking acute paediatrics, CYPCS and radiotherapy.
We also have a wide portfolio of clinical trials in all disease subtype, and you will have the opportunity to be actively involved as a sub-investigator.
You will be joining a friendly team to provide an excellent and comprehensive TYA Haematology/Oncology service within UCL Hospitals NHS Foundation Trust.
We encourage you to contact us to discuss this further and work out how this post could be right for you. For further information on this post, please contact Dr Valeria Fiaccadori (v.fiaccadori@nhs.net) or Dr Carmen Soto (carmen.soto@nhs.net).
Come and bea part of the best NHS trust in England to work for, according to our staff*
UCLH top trust to work at in England – for the second year running! : University College London Hospitals NHS Foundation Trust
*In the most recentNHS staff surveyUCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the second year in a row.
UCLH top trust to work at in England – for the second yearrunning!University College London Hospitals NHS Foundation Trust.
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work.
This advert closes on Wednesday 3 Jul 2024
We have an exciting opportunity for a Senior Clinical Fellow in TYA Haematology/Oncology (registrar/ST4+ equivalent), to join our busy and innovative Children’s and Young People’s Cancer Services [CYPCS] at UCLH from September 2024.
The post is for 12 months from September 2024. It is a 40-hour post: 8.30am to 5pm Monday to Friday, for on-call commitment for this post refer attached Job Description, which includes covering general paediatrics/paediatric emergency department.
This post will be comprised of 80% clinical activity and 20% for special interest activities, including disease focused research, service development projects, leadership and management skills training, diagnostics lab attachments.
Eligible for full registration with the GMC at time of appointment and hold a current licence to practise.
Full GMC Registration. NB: Non-UK trained doctors must be on the GMC register by date of interview.
This vacancy may close before the current listed closing date. Therefore, if you intend to apply for this post, you are advised not to delay submitting your completed application.
As part of the job, you will have the chance to develop expertise in a variety of subspecialities:
- Acute and chronic leukaemia’s
- Hodgkin and non-Hodgkin lymphomas
- Non-malignant haematology
- Neuro-oncology
- Sarcomas
- Rare tumours
- Bone Marrow Transplant (autologous and allogeneic)
- CAR T cells therapy
- Proton Beam Therapy
- Lab diagnostics (flow cytometry/cytogenetics/molecular/histopathology)
University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research.
We provide first-class acute and specialist services across eight sites:
• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing)
• National Hospital for Neurology and Neurosurgery
• Royal National ENT and Eastman Dental Hospitals
• University College Hospital Grafton Way Building
• Royal London Hospital for Integrated Medicine
• University College Hospital Macmillan Cancer Centre
• The Hospital for Tropical Diseases
• University College Hospital at Westmoreland Street
We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women’s health and the treatment of cancer, infection, neurological,gastrointestinaland oral disease. It has world class support services including critical care, imaging, nuclearmedicineand pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.
For the full Person Specification and more informationregardingthe main responsibilities of this role, please refer to the attached Job Description.
The TYA Service at UCLH is the largest in the world, attracting an international reputation, with regular visits from experts from around the globe. We provide comprehensive tertiary care for patients from diagnosis, through to survivorship or palliative care. We provide all aspects of state-of-the-art cancer care and are a quaternary centre for specific treatments, including radio-isotope therapy and proton beam therapy. The clinical service is enhanced by exceptional clinical and translational research based within University College London and the Institute of Child Health.
All patients aged 0-18 years with a diagnosis of cancer, within the North Thames TYA Cancer Network are referred into the UCLH/GOSH Principal Treatment Centre. Patients aged 19-24 years are offered the choice to be referred to UCLH or to be treated at local Designated Hospitals within the Operational Delivery Network (ODN).
The newly opened Grafton Way Hospital houses the Proton Beam Therapy (PBT) Centre, one of only two sites in the UK. PBT offers innovative radiotherapy for certain cancer patients, with children making a significant proportion providing new models of care, synergistic clinical provision and research opportunities. These children require extensive supportive and POSCU-like care, offering opportunities for the development of new services linking acute paediatrics, CYPCS and radiotherapy.
We also have a wide portfolio of clinical trials in all disease subtype, and you will have the opportunity to be actively involved as a sub-investigator.
You will be joining a friendly team to provide an excellent and comprehensive TYA Haematology/Oncology service within UCL Hospitals NHS Foundation Trust.
We encourage you to contact us to discuss this further and work out how this post could be right for you. For further information on this post, please contact Dr Valeria Fiaccadori (v.fiaccadori@nhs.net) or Dr Carmen Soto (carmen.soto@nhs.net).
Come and bea part of the best NHS trust in England to work for, according to our staff*
UCLH top trust to work at in England – for the second year running! : University College London Hospitals NHS Foundation Trust
*In the most recentNHS staff surveyUCLH had the highest percentage of staff who said they would recommend us as a place to work, out of all general acute or acute/community NHS trusts in England – for the second year in a row.
UCLH top trust to work at in England – for the second yearrunning!University College London Hospitals NHS Foundation Trust.
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work.
This advert closes on Wednesday 3 Jul 2024
Aelod balch o'r cynllun cyflogwyr Hyderus o ran Anabledd
Hyderus o ran Anabledd
Gwybodaeth am Hyderus o ran Anabledd
Yn gyffredinol, bydd cyflogwr Hyderus o ran Anabledd yn cynnig cyfweliad i unrhyw ymgeisydd sy'n datgan eu bod yn anabl ac yn bodloni'r meini prawf lleiaf ar gyfer y swydd fel y diffinnir gan y cyflogwr. Mae'n bwysig nodi, mewn rhai sefyllfaoedd recriwtio fel nifer fawr o ymgeiswyr, cyfnod tymhorol ac amseroedd prysur iawn, efallai y bydd y cyflogwr am gyfyngu ar y niferoedd cyffredinol o gyfweliadau a gynigir i bobl anabl a phobl nad ydynt yn anabl. Am fwy o fanylion ewch i Hyderus o ran Anabledd.